venture capital

Carlyle's acquisition of Abingworth brings $2 billion to fuel life science investments
Fierce Biotech
Tue, 04/12/22 - 08:57 pm
Carlyle Group
Abingworth
venture capital
Another RA-backed biotech hits Nasdaq as public market stirs again after a bruising first quarter
Endpoints
Fri, 03/25/22 - 10:29 am
AN2 Therapeutics
lung disease
funding
RA Capital
venture capital
IPOs
Bayer-backed Affini-T snags $175M to enter increasingly crowded KRAS-cancer field
Fierce Biotech
Tue, 03/22/22 - 10:09 am
Affini-T Therapeutics
venture capital
Bayer
KRAS
Plexium nabs $102M for protein degradation work weeks after $500M Amgen tie-up
Fierce Biotech
Wed, 02/23/22 - 10:34 am
Plexium
Amgen
protein degradation
venture capital
funding
Hunting for cutting-edge biotech, Fujifilm sets up early-stage VC fund
Fierce Biotech
Fri, 02/11/22 - 10:32 am
Fujifilm
venture capital
funding
Medtech scores its biggest-ever venture haul
EP Vantage
Mon, 01/17/22 - 10:42 am
devices
Medtech
venture capital
Caris Life Sciences
CMR Surgical
Freenome
Element Biosciences
Quanta
Imperative Care
Exo
Cue Health
Intervenn Biosciences
In 2021 it paid to stay private for biotech
EP Vantage
Wed, 01/5/22 - 10:38 am
biotech
funding
venture capital
Science, talent, money: Eir raises $138M VC fund to fill gap in Nordic life science scene
Fierce Biotech
Thu, 12/9/21 - 10:34 am
Eir
funding
Nordic
venture capital
Sweden
Denmark
Europe
Merck KGaA's venture arm is ready to make new investments, raising more than $675M to get things going
Endpoints
Wed, 12/8/21 - 10:41 am
Merck KGaA
venture capital
M Ventures
Europe
Apollo's mission to extend human health span gets $180M boost, giving VC fund a launchpad for age-related disease biotechs
Fierce Biotech
Wed, 12/1/21 - 10:26 am
Apollo Health Ventures
age-related disease
funding
venture capital
Signet Therapeutics gets a $10M top-up for next-gen cancer bets
Fierce Biotech
Fri, 10/29/21 - 11:07 am
Signet Therapeutics
funding
venture capital
China
cancer
oncology
Frazier has raised an $830M public life science fund. Here's how it plans to invest the cash
Fierce Biotech
Thu, 10/28/21 - 10:13 pm
Frazier Healthcare
funding
life sciences
venture capital
VCs back Leucid to trial CAR-T twist in ovarian cancer patients
Fierce Biotech
Thu, 10/21/21 - 10:40 am
Leucid Bio
CAR-T
ovarian cancer
clinical trials
venture capital
Another big year beckons for biotech venture financing
EP Vantage
Tue, 10/12/21 - 10:56 am
biotech
venture capital
funding
Abogen
Laronde Therapeutics
Sonoma Biotherapeutics
Altos Labs
Deep Genomics
GraphWear tallies up $20M VC funding for needle-free wearable glucose monitor
Fierce Biotech
Wed, 10/6/21 - 12:00 am
GraphWear
funding
diabetes
CGM
continuous glucose monitoring
venture capital
devices
Medtech
Merck KGgA venture arm bets on ‘next generation’ cancer therapeutics player
Biopharma Reporter
Tue, 10/5/21 - 10:53 am
Merck KGaA
M Ventures
venture capital
iOmx Therapeutics
cancer
funding
Time for round 2: Illumina-backed VC snags $325M for its next fund
Endpoints
Mon, 09/20/21 - 11:08 am
Illumina Ventures
venture capital
funding
genomics
Pfizer backs a small Swiss upstart's attempt to discover a non-viral gene therapy
Endpoints
Thu, 09/16/21 - 10:48 am
gene therapy
Switzerland
Pfizer
venture capital
funding
Anjarium Biosciences
Venture capital pours more money into RNA medicines with the launch of Replicate
BioPharma Dive
Wed, 09/8/21 - 11:10 am
RNA
venture capital
Replicate Biosciences
Apple Tree Partners
Disc Medicine nabs $90M for blood disease pipeline, new Roche asset
Fierce Biotech
Thu, 09/2/21 - 09:34 am
Disc Medicine
funding
blood disease
venture capital

Pages